Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)
- L Silveira-Moriyama1,
- P Schwingenschuh2,6,
- A O’Donnell3,
- S A Schneider2,
- P Mir4,
- F Carrillo4,
- C Terranova2,
- A Petrie5,
- D G Grosset3,
- N P Quinn2,
- K P Bhatia2,
- A J Lees1
- 1Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK
- 2Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK
- 3Institute of Neurological Sciences, Department of Neurology, Southern General Hospital, Glasgow, UK
- 4Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBERNED, Seville, Spain
- 5Biostatistics Unit, UCL Eastman Dental Institute, London, UK
- 6Department of Neurology, Medical University Graz, Austria
- Professor A Lees, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1 Wakefield St, London WC1N 1PJ, UK; alees{at}ion.ucl.ac.uk
- Received 16 January 2009
- Revised 18 February 2009
- Accepted 26 February 2009
- Published Online First 9 March 2009
Abstract
Background: Positron emission tomography and single photon emission computed tomography scanning have 87–94% sensitivity and 80–100% specificity to differentiate patients with Parkinson’s disease (PD) from control subjects and patients with essential (ET) or atypical tremor. More than 10% of patients diagnosed as early PD can have scans without evidence of dopaminergic deficiency (SWEDDs). This study investigated whether smell tests can help identify possible cases with SWEDDs.
Methods: The 40 item University of Pennsylvania Smell Test (UPSIT) was used to evaluate the sense of smell in 21 SWEDDs patients. Twenty-six ET patients, 16 patients with a diagnosis of idiopathic adult onset dystonia (D), 191 non-demented PD patients and 136 control subjects were also tested. Multiple regression analyses were used to compare the mean UPSIT score in the SWEDDs group with the other four groups (ET, D, PD and controls) after adjusting for the effects of relevant covariates.
Results: The mean UPSIT score for the SWEDDs group was greater than in the PD group (p<0.001) and not different from the mean UPSIT in the control (p = 0.7), ET (p = 0.4) or D (p = 0.9) groups. Smell tests indicated a high probability of PD in only 23.8% of SWEDDs as opposed to 85.3% of PD patients.
Conclusions: In a patient with suspected PD, a high PD probability on smell testing favours the diagnosis of PD, and a low PD probability strengthens the indication for dopamine transporter imaging.
Footnotes
-
Competing interests: None.
-
Funding: This work was funded by the Reta Lila Weston Trust for Medical Research and LS-M is a beneficiary of a Reta Lila Weston fellowship. PS was funded by the Austrian Science Fund (FWF, Erwin Schrödinger Grant).
-
Ethics approval: Ethics Committee approval was obtained from the regional and local ethics committee in the National Hospital for Neurology and Neurosurgery, London, UK and regional and local ethics committee in the Southern General Hospital, Glasgow, UK.
